Prof. Rudolf Jaenisch joins ImStem Biotechnology as Member of its Scientific Advisory Board

ImStem Biotechnology today announced that Prof. Rudolf Jaenisch joins ImStem Biotechnology as Member of Scientific Advisory Board.

Rudolf Jaenisch is a Professor of Biology at MIT and a founding member of the Whitehead Institute for Biomedical Research. He is a pioneer in transgenic science, creating genetically modified mice to study cancer, neurological and connective tissue diseases, and developmental abnormalities, some of which have produced important advances in these disease areas.

His current research passion lies in the epigenetic regulation of gene expression, which has led to major breakthroughs in creating human embryonic stem cells (hESC) and  induced pluripotent stem  (iPS) cells, as well as their therapeutic applications. Additional research focuses on the epigenetic mechanisms involved in cancer and brain development.

“Prof. Jaenisch is an important addition to the scientific advisory board of ImStem,” said Michael Men, Chairman of the Board of ImStem. “We've been following his achievements for years and we know he will work closely with us to continue to push ImStem to the forefront of stem cell therapy."

Rudolf Jaenisch got his MD in 1967 from University of Munich. He holds numerous awards and honors including: 2001 Inaugural Genetics Prize of the Gruber Foundation, 2002 Robert Koch Prize, 2006 Max Delbrück Medal, 2007 Vilcek Prize in Biomedical Science, 2009 Ernst Schering Prize, 2010 National Medal of Science, 2011 Wolf Prize in Medicine, 2012 International Society for Stem Cell Research McEwen Innovation Award, 2013 Benjamin Franklin Medal in Life Science from the Franklin Institute, 2013 Passano Award, 2014 Otto Warburg Medal and 2015 March of Dimes Prize in Developmental Biology.